ArticleFrontiers in immunology2024

SHR-8068 combined with adebrelimab and bevacizumab in the treatment of refractory advanced colorectal cancer: study protocol for a single-arm, phase Ib/II study.

Pei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.